Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PTC Therapeutics Inc (NASDAQ:PTCT)

16.13
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
8.12
Today|||52-Week Range
22.00
+47.85%
Year-to-Date
No recent news for PTC Therapeutics Inc.

Today’s Trading

Previous close16.13
Today’s open15.99
Day’s range15.69 - 16.48
Volume2,363,048
Average volume (3 months)1,104,635
Market cap$669.2M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+17.75%
Earnings growth (this year)+43.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+124.95%
P/E ratioNM
Price/Sales4.49
Price/Book4.61

Competitors

 Today’s
change
Today’s
% change
TGTXTG Therapeutics Inc0.000.00%
ADROAduro Biotech Inc0.000.00%
EGRXEagle Pharmaceutical...0.000.00%
ENTAEnanta Pharmaceutica...0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$82.7M
Annual profit (last year)-$142.1M
Net profit margin-171.83%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Chief Operating Officer
Marcio Souza
Corporate headquarters
South Plainfield, New Jersey

Forecasts